These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
    Author: Sakai K, Kuromaru O, Akima M, Yoshizawa M.
    Journal: Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):119-25. PubMed ID: 4062428.
    Abstract:
    The cardiovascular effects of SGB-1534 (3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]-2,4(1H,3H)-quinazolinedione monohydrochloride) were investigated in pentobarbital-anesthetized miniature pigs. SGB-1534 infused i.v. at a rate of 3 micrograms/kg . hr-1 caused a gradual decrease of systemic blood pressure reaching a plateau level, with a peak fall of about 20% of the preinfusion value, 30-60 min after the start of the infusion. Significant reductions of coronary vascular resistance and left ventricular (LV) end-diastolic pressure were also observed. Changes in LV systolic pressure, coronary blood flow and pressure-rate product were not significant, while heart rate and LVdp/dt max were significantly increased. The pressor response to a bolus i.v. injection of epinephrine (1 microgram/kg) was significantly inhibited during i.v. infusion of SGB-1534. The results indicate that SGB-1534 is an antihypertensive agent, probably related to its alpha-adrenergic blocking action in peripheral vasculatures.
    [Abstract] [Full Text] [Related] [New Search]